Holly Difebo

Nivolumab in Advanced Hepatocellular Carcinoma: Safety Profile and Select Treatment‐Related Adverse Events From the CheckMate 040 Study

M. Tschaika, J. Koh, Yun Shen, 2020, The oncologist.

Final report of a phase I/II study of veliparib (Vel) in combination with 5-FU and oxaliplatin (FOLFOX) in patients (pts) with metastatic pancreatic cancer (mPDAC).

J. Marshall, L. Weiner, Hongkun Wang, 2019, Journal of Clinical Oncology.

Controlled trial of safety and efficacy of bright light therapy vs. negative air ions in patients with bipolar depression

M. Terman, N. Rosenthal, J. Rosenthal, 2012, Psychiatry Research.